Insulin, Cation Metabolism And Insulin Resistance

Journal of Basic and Clinical Physiology and Pharmacology

Volumn 9, Issue 2-4, 1998, Pages 223-234

  Sowers, James R ^a   Draznin, Boris ^a  

^a WAYNE STATE UNIVERSITY   (United States)

Author keywords

cations; insulin; insulin like growth factor; resistance

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATE; ANGIOTENSIN; ARGININE DERIVATIVE; CALCIUM ION; CATION; GLUCOSE; GROWTH FACTOR; INSULIN; MAGNESIUM ION; N(G) METHYLARGININE; NITRIC OXIDE; PROSTACYCLIN; SOMATOMEDIN;

ENZYME ACTIVITY; GLUCOSE TRANSPORT; HUMAN; INSULIN RESISTANCE; METABOLISM; NONHUMAN; OXIDATIVE STRESS; PHOSPHORYLATION; REVIEW; VASCULAR SMOOTH MUSCLE;

ANIMALS; CATIONS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR I; MAGNESIUM; MUSCLE, SMOOTH, VASCULAR; RATS;

EID: 0032465991     PISSN: 07926855     EISSN: 21910286     Source Type: Journal    
DOI: 10.1515/JBCPP.1998.9.2-4.223     Document Type: Article

References (65)

1. American Diabetes Association. Consensus development conference on insulin resistance. Diabetes Care 1998; 21: 310–314.
2. Reaven, GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595–1607.
3. Martin, BC., Warram, JH., Krolewski, AS., Bergman, RN., Soeldner, JS., Kahn, CR. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 1992; 340: 925–929.
4. Draznin, B. Insulin signaling network-waiting for Copernicus [editorial]. Endocrinology 1996; 137: 2647–2648.
5. Saltiel, AR. Diverse signaling pathways in the cellular actions of insulin. Am J Physiol 1996; 270: E375-E385.
6. Sowers, JR. Effects of insulin and IGF-1 on vascular smooth muscle glucose and cation metabolism. Diabetes 1996; 45: S47-S51.
7. Kelly, D., Mitrakou, A., Marsh, H., Schwenk, F., Benn, J., Sonenberg, G., Arcangeli, M., Aoki, T., Sorensel, J., Berger, M., Sonksen, P., Gerich, J. Skeletal muscle glycolysis, o.xidation, and storage of an oral glucose load. J Clin Invest 1988; 81: 1563–1571.
8. Natali, A., Bonadonna, R., Santoro, D., Galvan, AQ., Baldi, S., Frascerra, S., Palombo, C., Ghione, S., Ferrannini, E. Insulin resistance and vasodilation in essential hypertension: studies with adenosine. J Clin Invest 1994; 94: 1570–1576.
9. 18FJfluoro-deoxy-glucose and positron emission tomography. J Clin Invest 1996; 97: 1741–1747.
10. 2+-induced inhibition of insulin-stimulated glucose transport. J Biol Chem 1993; 268: 3352–3356.
11. Zemel, MB., Peuler, JD., Sowers, JR. Hypertension in insulin-resistant Zucker obese rats is independent of sympathetic neural support. Am J Physiol 1992; 262: E368-E371.
12. Standley, PR., Ram, JL., Sowers, JR. Insulin attenuation of vasopressin-induced calcium responses in arterial smooth muscle from Zucker rats. Endocrinology 1993; 133: 1693–1699.
13. Standley, PR., Rose, KA., Sowers, JR. Increased basal arterial smooth muscle glucose transport in the Zucker rat. Am J Hypertens 1995; 8: 48–52.
14. Sowers, JR. Insulin and insulin-like growth factor in normal and pathological cardiovascular physiology. Hypertension 1997; 29: 691–699.
15. Dohn, CL., Elton, CS., Madhu, S., et al. IGF-1 stimulated glucose transport in human skeletal muscle and IGF-1 resistance in obesity and NIDDM. Diabetes 1990; 39: 1028–1031.
16. Jacob, RJ., Sherwin, RS., Greenwalt, K., Shulman, GI. Simultaneous insulin-like growth factor-1 and insulin resistance in obese Zucker rats. Diabetes 1992; 41: 691–697.
17. Liu, S., Baracos, VE., Quinney, HA., Bricon, TH., Clandinin, MT. Parallel insulin-like growth factor-1 and insulin resistance in muscles of rats fed a high fat diet. Endocrinology 1995; 136: 3318–3324.
18. 2+and nitric oxide in diabetes. In: Levin ER, Nadler JL, eds. Endocrinology of Cardiovascular Function. Boston, MA: Kluwer Academic Publishers, 1998; 139–158.
19. Bakris, GL., Standley, PR., Palant, CE., Walsh, MF., Sowers, JR. Analogy between endothelial mesangial cell and endothelial vascular smooth muscle interactions: role of growth factors and mechanotransduction. In: Sowers JR, ed. Contemporary Endocrinology: Endocrinology of the Vasculature. Totowa, NJ: Humana Press, 1996; 341–355.
20. Donohue, TJ., Dworkin, LD., Lango, MN., et al. Induction of myocardial insulin-like growth factor-1 gene expression in left ventricular hypertrophy. Circulation 1994; 89: 799–809.
21. Kolter, T., Uphues, I., Eckel, J. Molecular analysis of insulin-resistance in isolated ventricular cardiomyocytes of obese Zucker rats. Am J Physiol 1997; 36: E59-E67.
22. Murphy, LJ., Ghahary, A., Chakrabarti, S. Insulin regulation of IGF-1 expression in rat aorta. Diabetes 1990; 39: 657–661.
23. Bornfeldt, KE., Arnqvist, HJ., Norstedt, G. Regulation of insulin-like growth factor-1 gene expression by growth factors in cultured vascular smooth muscle cells. J Endocrinol 1990; 125: 381–386.
24. Khorsandi, MJ., Fagin, JA., Giannella-Neto, D., Forrester, JS., Cercek, B. Regulation of insulin-like growth factor-1 and its receptor in rat aorta after balloon denudation. Evidence for local bioactivity. J Clin Invest 1992; 90: 1926–1931.
25. Delafontaine, P., Lou, H. Angiotensin II regulates insulin-like growth factor 1 gene expression in vascular smooth muscle cells. J Biol Chem 1993; 268: 16866–16870.
26. Delafontaine, P. Lou, H., Alexander, RW. Regulation of insulin-like growth factor 1 messenger RNA levels in vascular smooth muscle cells. Hypertension 1994; 18: 742–747.
27. Standley, PR., Zhang, F., Ram, JL., Zemel, MB., Sowers, JR. Insulin attenuates vasopressin-induced calcium transient and voltage-dependent calcium response in rat vascular smooth muscle cells. J Clin Invest 1991; 88: 1230–1236.
28. Saito, F., Hori, MT., Fittingott, M., Hino, R. Tuck, ML. Insulin attenuates agonist-mediated calcium mobilization in cultured rat vascular smooth muscle cells. J Clin Invest 1993; 92: 1161–1168.
29. Kahn, AM., Seidel, CL., Allen, JC., O'Neil, RG., Shelat, H., Song, T. Insulin reduces contraction and intracellular calcium concentration in vascular smooth muscle. Hypertension 1993; 22: 735–742.
30. Ram, JL., Fares, MA., Standley, PR., Sowers, JR. Insulin inhibits vasopressin elicited contraction of vascular smooth muscle cells. J Vascular Med Biol 1993; 4: 250–255.
31. Touyz, RM., Tolloczko, B., Schiffrin, EL. Insulin attenuates agonist evoked calcium transients in vascular smooth muscle cells. Hypertension 1994; 23: 123–128.
32. Kahn, AM., Husid, A., Allen, JC., Seidel, CL., Song, T. Insulin acutely inhibits cultured vascular smooth muscle cell contraction by a nitric oxide synthase-dependent pathway. Hypertension 1997; 30: 929–933.
33. Bolotina, VM., Najibl, JJ., Pagano, PJ., Cohen, RA. Nitric oxide directly activates calcium dependent potassium channels in vascular smooth muscle. Nature 1994; 368: 850–853.
34. +channels. Am J Physiol 1996; 271: H1498-H1506.
35. +-ATPase gene expression by insulin in vascular smooth muscle cells. Am J Hypertens 1993; 6: 626–629.
36. +-ATPase in rat aorta. Diabetes 1991; 40: 1560–1563.
37. +-ATPase from intracellular compartments to the plasma membrane in mammalian skeletal muscle. J Biol Chem 1992; 267: 5040–5043.
38. +-ATPase in rat arterial smooth muscle. Am J Physiol 1997; 273: El13-E121.
39. +)-ATPase. J Biol Chem 1985; 260: 1075–1080.
40. +)-ATPase transport activity in muscle. J Biol Chem 1985; 260: 6206–6212.
41. Steinberg, HO., Brechtel, G., Johnson, A., Feneberg, N., Baraon, AD. Insulinmediated skeletal muscle vasodilation is nitric oxide-dependent: a novel action of insulin to increase nitric oxide release. J Clin Invest 1994; 94: 1172–1179.
42. Walsh, MF., Barazi, M., Pete, G., Muniyappa, R., Dunbar, JC., Sowers, JR., IGF-1 diminishes in vivo and in vitro vascular contractility: role of vascular nitric oxide. Endocrinology 1996: 137: I798-I803
43. +)-ATPase activity by nitric oxide: a cGMP-independent effect. Am J Physiol 1994; 266: H2I46-H2151
44. +)-ATPase activity and its all subunit gene expression in rat skeletal muscle: influence of diabetes, fasting and refeeding. Metabolism 1992; 41: 56–63
45. +)-ATPase in rat aorta. Diabetes 1991; 40: 1560–1563
46. +)-ATPase in isolated cerebral microvessels. Am J Physiol 1993; 265: E777-E782
47. Dominguez, LJ., Peuler, JD., Sowers, JR. Endocrine regulation of vascular smooth muscle intermediary metabolism. In: Sowers JR. ed. Endocrinology of the Vasculature. Totowa, NJ: Humana Press, 1996; 325–339.
48. Sowers, JR., Epstein, M. Diabetes mellitus and associated hypertension, vascular disease, and nephropathy: an update. Hypertension 1995; 26: 86987
49. Levy, J., Gavin, JR. III, Sowers, JR. Diabetes mellitus: a disease of abnormal cellular calcium metabolism? Am J Med 1994; 96: 260–272.
50. Reddy, S., Shehin, MS., Sowers, JR. Aortic calcium-45 flux and blood pressure regulation in streptozotocin-induced diabetic rats. Vasc Biol 1990; 2: 47–51
51. +-dependent adenosine triphosphatase activity in the maintenance of elevated blood pressure in obesity: effects of weight loss. Clin Sci 1982; 63: 121S-124S.
52. +)-ATPase activity in kidney basolateral membrane on non-insulin dependent diabetic rats, Biochem Biophys Res Comm 1987; 193: 1313–1319.
53. +-ATPase in rat aorta. Diabetes 1991; 40: 1560–1563.
54. +-ATPase a subunit gene expression in hypertension. Science 1988; 241: 221–223.
55. Sada, T., Koike, H., Ikeda, M., Sato, K. Ozaki, H., Karaki, H. Cytosolic free calcium of aorta in hypertensive rats. Hypertension 1990; 16: 245–251
56. Hulmán, S., Falkner, B., Chen, YQ. Insulin resistance in the spontaneously hypertensive rat. Metabolism 1991: 40: 359–361.
57. Turlapaty, PDMV., Altura, BM. Magnesium deficiency produces spasms of coronary arteries: relationship to etiology of sudden death ischemic heart disease. Science 1980; 208: 198–200.
58. Rayssiguier, Y. Magnesium. lipids and vascular diseases; experimental evidence in animal models. Magnesium 1986; 5: 182–190.
59. Zemel, PC. Zemel, M. Urberg, M., Douglas, F., Sowers, JR. Metabolic and hemodynamic effects of magnesium supplementation in patients with essential hypertension. Am J Clin Nutr 1990; 51: 665–669.
60. Paolisso, G. Sgambato, S. Pizza, G. Passariello, N., Varricchio, M. D'Onofrio, F. Improved insulin response and action by chronic magnesium administration in aged NIDDM subjects. Diabetes Care 1989; 12: 265–268.
61. Balon, JTW. Gu, JL., Tokuyama, Y., Jasman, AP., Nadler, JL. Magnesium supplementation reduces development of diabetes in a rat model of spontaneous NIDDM. Am J Physiol 1995; E745-E752.
62. Nadler, JL., Buchanan, T., Natarajan, R. Antonipillai, I., Bergman, R., Rude, R. Magnesium deficiency produces insulin resistance and increased thromboxane synthesis. Hypertension 1993; 21: 1024–1029.
63. Dominguez, LJ. Barbagallo, M., Sowers, JR. Resnick, LM. Magnesium responsiveness to insulin and IGF-1 in erythrocytes from normotensive and hypertensive subjects. J Clin Endocrinol Metab (submitted).
64. Dickens, BF. Weglicki, Y., Li, S., Mak, IT. Magnesium deficiency in vitro enhances free radical-induced intracellular oxidation and cytotoxicity in endothelial cells. FEBS Lett 1992; 311: 187–191.
65. Sipes, SL., Weiner, CP., Gelhaus, TM., Goodspeed, JD. Effects of magnesium sulfate infusion upon plasma prostaglandins in preeclampsia and preterm labor. Hypertens Pregnancy 1994; 13: 293–302.